JP2021534104A5 - - Google Patents
Info
- Publication number
- JP2021534104A5 JP2021534104A5 JP2021506660A JP2021506660A JP2021534104A5 JP 2021534104 A5 JP2021534104 A5 JP 2021534104A5 JP 2021506660 A JP2021506660 A JP 2021506660A JP 2021506660 A JP2021506660 A JP 2021506660A JP 2021534104 A5 JP2021534104 A5 JP 2021534104A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- independently selected
- cycloalkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862715845P | 2018-08-08 | 2018-08-08 | |
| US62/715,845 | 2018-08-08 | ||
| PCT/US2019/045459 WO2020033514A1 (en) | 2018-08-08 | 2019-08-07 | Benzimidazole inhibitors of pad enzymes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534104A JP2021534104A (ja) | 2021-12-09 |
| JP2021534104A5 true JP2021534104A5 (cg-RX-API-DMAC10.html) | 2022-08-16 |
| JP7434281B2 JP7434281B2 (ja) | 2024-02-20 |
Family
ID=67766305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506660A Active JP7434281B2 (ja) | 2018-08-08 | 2019-08-07 | Pad酵素のベンズイミダゾール阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12692254B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3833439B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7434281B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20210042933A (cg-RX-API-DMAC10.html) |
| CN (1) | CN112789087B (cg-RX-API-DMAC10.html) |
| ES (1) | ES2956090T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020033514A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3833440A1 (en) | 2018-08-08 | 2021-06-16 | Bristol-Myers Squibb Company | Indole and azaindole inhibitors of pad enzymes |
| ES2929200T3 (es) | 2018-08-08 | 2022-11-25 | Bristol Myers Squibb Co | Tienopirroles sustituidos como inhibidores de PAD4 |
| ES2956090T3 (es) | 2018-08-08 | 2023-12-13 | Bristol Myers Squibb Co | Inhibidores de bencimidazol de enzimas PAD |
| CN115298175B (zh) | 2020-02-06 | 2024-05-07 | 百时美施贵宝公司 | 可用作免疫抑制剂的大环pad4抑制剂 |
| TW202140477A (zh) | 2020-02-12 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 雜環pad4抑制劑 |
| MX2022013615A (es) | 2020-04-30 | 2022-11-16 | Gilead Sciences Inc | Inhibidores de macrociclo de peptidilarginina deiminasas. |
| EP4267562A1 (en) | 2020-12-22 | 2023-11-01 | Gilead Sciences, Inc. | Inhibitors of peptidylarginine deiminases |
| TW202233174A (zh) | 2020-12-22 | 2022-09-01 | 美商基利科學股份有限公司 | 肽基精胺酸去亞胺酶之抑制劑 |
| WO2025024265A1 (en) | 2023-07-21 | 2025-01-30 | Bristol-Myers Squibb Company | Methods of assessing citrullination and activity of pad4 modulators |
| WO2026020127A2 (en) | 2024-07-19 | 2026-01-22 | Bristol-Myers Squibb Company | Methods of assessing citrullination and activity of pad2 modulators |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1214330A1 (en) | 1999-09-21 | 2002-06-19 | LION Bioscience AG | Benzimidazole derivatives and combinatorial libraries thereof |
| US8470819B2 (en) * | 2008-11-03 | 2013-06-25 | Merck Sharp & Dohme Corp. | Benzimidazole and aza-benzimidazole carboxamides |
| RU2611010C2 (ru) * | 2012-07-26 | 2017-02-17 | Глаксо Груп Лимитед | 2-(Азаиндол-2-ил)бензимидазолы в качестве ингибиторов PAD4 |
| WO2016185279A1 (en) * | 2015-05-21 | 2016-11-24 | Glaxosmithkline Intellectual Property Development Limited | Benzoimidazole derivatives as pad4 inhibitors |
| AR107030A1 (es) | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores aza-bencimidazol de pad4 |
| AR107032A1 (es) * | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores bicíclicos de pad4 |
| CN108602812B (zh) | 2015-12-22 | 2021-11-02 | 坎塞拉有限公司 | 可用作哺乳动物组蛋白去乙酰化酶活性的抑制剂的双环异羟肟酸类化合物 |
| SG11201807021UA (en) | 2016-02-23 | 2018-09-27 | Padlock Therapeutics Inc | Heteroaryl inhibitors of pad4 |
| US10703741B2 (en) * | 2016-07-27 | 2020-07-07 | Padlock Therapeutics, Inc. | Covalent inhibitors of PAD4 |
| KR102502992B1 (ko) | 2016-09-12 | 2023-02-24 | 패들락 테라퓨틱스, 인코포레이티드 | Pad4의 헤테로아릴 억제제 |
| CN107311933B (zh) * | 2017-06-28 | 2020-12-22 | 中国人民解放军军事医学科学院毒物药物研究所 | 一类苯并咪唑衍生物,及其制备方法和用途 |
| JP7311228B2 (ja) | 2017-06-30 | 2023-07-19 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用 |
| CN111225915B (zh) | 2017-10-18 | 2023-03-07 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的咪唑并吡啶化合物 |
| ES2929200T3 (es) | 2018-08-08 | 2022-11-25 | Bristol Myers Squibb Co | Tienopirroles sustituidos como inhibidores de PAD4 |
| MX2021001471A (es) | 2018-08-08 | 2021-04-28 | Bristol Myers Squibb Co | Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4). |
| EP3833440A1 (en) | 2018-08-08 | 2021-06-16 | Bristol-Myers Squibb Company | Indole and azaindole inhibitors of pad enzymes |
| ES2956090T3 (es) | 2018-08-08 | 2023-12-13 | Bristol Myers Squibb Co | Inhibidores de bencimidazol de enzimas PAD |
-
2019
- 2019-08-07 ES ES19759140T patent/ES2956090T3/es active Active
- 2019-08-07 US US17/265,840 patent/US12692254B2/en active Active
- 2019-08-07 JP JP2021506660A patent/JP7434281B2/ja active Active
- 2019-08-07 CN CN201980064964.3A patent/CN112789087B/zh active Active
- 2019-08-07 EP EP19759140.7A patent/EP3833439B1/en active Active
- 2019-08-07 KR KR1020217006470A patent/KR20210042933A/ko not_active Ceased
- 2019-08-07 WO PCT/US2019/045459 patent/WO2020033514A1/en not_active Ceased